DrugDashboards

Naproxen

Naproxen · NAPROXEN 125 mg/5mL · Suspension · Oral · Acella Pharmaceuticals, LLC

NDC 42192-0619-16 · 473 mL in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price has fallen 69% in a year, to $0.1173 per mL — and generics that get this cheap tend to get abandoned rather than defended. A Class II recall hit this product in the past year (Acella Pharmaceuticals, LLC). Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1173per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1692per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal ceiling (Big4)$34.13per package of 473MLAvion Pharmaceuticals, LLC · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Mar 2023Sep 2026$0.1173
31 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$99.99
Reported to Texas DSHS · 2025 annual filing · Acella Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$151,579
711 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

35Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 5 active manufacturers+5
  • Class I/II recall in past 12 months+15
  • price down 65% year over year+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for naproxen (other) in the next 90 days

sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA018965
TE code
AB
Approval date
Mar 23, 1987
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingApr 20, 2026
    Acella Pharmaceuticals, LLCChemical contamination; presence of lead and lithium above specification

Manufacturers of Naproxen (Suspension)

LabelerStrengthFirst seenLast seen
Acella Pharmaceuticals, LLCNAPROXEN 125 mg/5mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCNAPROXEN 25 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedNAPROXEN 125 mg/5mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.NAPROXEN 25 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.NAPROXEN 125 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Naproxen — NDC 42192-0619-16," retrieved September 3, 2026, https://drugdashboards.com/drug/42192061916.

Free to cite with attribution — see how the data is put together.